- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Medivation and Astellas initiate phase 3 study of enzalutamide in non-metastatic castration-resistant prostate cancer
December 3, 2013
Management of patients with castration-resistant disease - Abstract
December 3, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer - Abstract
December 3, 2013
Radium Ra 223 dichloride injection: U.S. Food and Drug Administration Drug Approval Summary - Abstract
December 3, 2013
Imaging in prostate carcinoma - Abstract
December 2, 2013
Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer - Abstract
December 2, 2013
Diffusion-weighted MRI, (11)C-choline PET and (18)F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma - Abstract
December 2, 2013
Focus on the screening for prostate cancer by PSA - Abstract
December 2, 2013
The non-hormonal treatment of metastatic prostate cancer - Abstract
November 29, 2013
Ductal adenocarcinoma of the prostate: Immunohistochemical findings and clinical significance - Abstract
November 29, 2013
Surgical management of prostate cancer - Abstract
November 29, 2013